CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 30 target
Drug / intervention
ApisSeptdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

In the news

3 articles

Matched to this trial by ClinicalIndexfrom reputable biotech & medical press.

Search/NCT01111695
NCT01111695Phase 2Completed

Open Label Study (Phase 2) to Evaluate the Safety, Tolerance and Efficacy of a Ionic Silver and Honey Preparation to Treat Chronic Wounds of the Lower Legs

University Hospital, Geneva·interventional·Posted Apr 27, 2010·Updated Sep 30, 2011

In Brief

A Phase 2 clinical trial evaluating ApisSept for Leg Ulcer. Completed, enrolled 30 participants across 1 site.

Detailed Summary

In this open study, the primary objective is to study the efficacy and clinical outcome of the chronic wounds treated with this preparation for 8 weeks on 30 adults. Evaluation will be based on standardised photographs and clinical data. The secondary objectives are to evaluate the tolerance and side effects of the honey based preparation in the management of chronic wounds.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLeg Ulcer
CountriesSwitzerland

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 27, 2010
Enrollment StartJan 1, 2010
Primary CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 16.2 years ago

Interventions

ApisSeptdevice

honey and ionic silver based dressing